TECH - BIO-TECHNE Corp
IEX Last Trade
73.005
-3.515 -4.815%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:00:43 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
19.80%
PREVIOUS CLOSE
CHG
CHG%
$76.52
-3.52
-4.59%
Fundamental analysis
40%
Profitability
43%
Dept financing
33%
Liquidity
75%
Performance
29%
Performance
5 Days
-0.19%
1 Month
-1.83%
3 Months
-2.56%
6 Months
-0.05%
1 Year
-5.79%
2 Year
-11.17%
Key data
Stock price
$73.00
DAY RANGE
$72.49 - $76.52
52 WEEK RANGE
$62.43 - $85.57
52 WEEK CHANGE
-$6.59
DIVIDEND
$0.08
EX-DIVIDEND DATE
08/19/2024
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Charles R. Kummeth
Region: US
Website: bio-techne.com
Employees: 3,000
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: bio-techne.com
Employees: 3,000
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services. Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy. Diagnostics and Genomics segment provides diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market.
Recent news